Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

New Primary Antibodies Are Launched by Creative Diagnostics for Bio-community

Creative Diagnostics
Posted on: 15 Mar 18

As a leading supplier of research products and custom services, Creative Diagnostics recently announces that it has added new primary antibodies to its existing antibodies portfolio, which are designed according to the scientific needs of global research institutes, universities and biotech and pharmaceutical companies, etc.

Creative diagnostics offers a wide range of high quality antibodies validated for use in multiplexed assays. It has primary antibodies to multiple forms of virtually every protein in the proteome including cytokines, adhesion molecules, proteases, neurotrophic factors, stem cell factors, signal transduction molecules, and developmental proteins. The newly added primary antibodies include blood group antibodies, small molecule antibodies, epigenetics antibodies, plant pathogens antibodies.

These new primary antibodies have been tested and validated on the lot level by Creative Diagnostics in-house team of scientists to make sure of the specificity, sensitivity, and reproducibility. The new addition of antibodies aims to help researchers easily find desired product information and resources in one place, as well as application protocols and technical information.

"Together with these new primary antibodies, such as matched antibodies pairs, tag antibodies, phospho-specific antibodies, and cardiac markers antibodies, Creative Diagnostics provides researchers with an excellent cross-section of laboratory antibodies, enabling us to bring high performance and cost-effective solutions to the biotechnology market. Creative Diagnostics will remain focused on our efforts to offer scientists with high quality antibodies for a variety of research and pharmaceutical applications. We’ll partner with customers to understand and address drug development challenges." said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.

"In addition, Creative Diagnostics offers thousands of monoclonal/polyclonal antibodies and conjugates validated for use in a variety of common applications including WB, FC, IHC, ICC, IF, IP, and more. We look forward to collaborating with global scientists in this community to address the challenges confronting in the study projects, and we’re excited to help them optimize results and accelerate life sciences research with our quality antibodies." added Dr. Randy S. Vaughn, senior researcher, Creative Diagnostics

Having trouble choosing primary antibodies? Please feel free to contact Creative Diagnostics at 1-631-619-7922 or email to

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers’ assay development and manufacturing needs.

For more information:

Editor's Details

Thomas Schmitt
Creative Diagnostics

Last updated on: 15/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.